These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4541544)

  • 1. Time-course of response to hypothalamic extract and multiple use of lesioned rats for CRF assay.
    Lymangrover JR; Brodish A
    Neuroendocrinology; 1973; 12(2):98-109. PubMed ID: 4541544
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for the existence of a corticotropin-releasing factor in the pigeon hypothalamus.
    Sato T; George JC
    Can J Physiol Pharmacol; 1973 Oct; 51(10):737-42. PubMed ID: 4543141
    [No Abstract]   [Full Text] [Related]  

  • 3. An in vitro assay for corticotropin releasing factor(s) using suspensions of isolated pituitary cells.
    Portanova R; Sayers G
    Neuroendocrinology; 1973; 12(4):236-48. PubMed ID: 4354350
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved parameters of pituitary incubation for the assay of corticotrophin-releasing factor.
    Seiden G; Brodish A
    Neuroendocrinology; 1971; 8(3):145-53. PubMed ID: 4328627
    [No Abstract]   [Full Text] [Related]  

  • 5. Extra-CNS corticotropin-releasing factors.
    Brodish A
    Ann N Y Acad Sci; 1977 Oct; 297():420-35. PubMed ID: 211911
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of ACTH priming on pituitary and adrenal function in hypophysectomized rats with ectopic pituitary grafts.
    Sirett NE; Purves HD
    Endocrinology; 1972 Feb; 90(2):579-84. PubMed ID: 4333140
    [No Abstract]   [Full Text] [Related]  

  • 7. Conditions for the reliable use of lesioned rats for the assay of CRF in tissue extracts.
    Witorsch RJ; Brodish A
    Endocrinology; 1972 Feb; 90(2):552-7. PubMed ID: 4333139
    [No Abstract]   [Full Text] [Related]  

  • 8. Diurnal rhythm of corticotropin-releasing factor activity in the pigeon hypothalamus.
    Sato T; George JC
    Can J Physiol Pharmacol; 1973 Oct; 51(10):743-7. PubMed ID: 4543142
    [No Abstract]   [Full Text] [Related]  

  • 9. Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin.
    Tizabi Y; Aguilera G
    Neuroendocrinology; 1992 Nov; 56(5):611-8. PubMed ID: 1336816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two distinct corticotrophin releasing activities of vasopressin.
    Buckingham JC
    Br J Pharmacol; 1985 Jan; 84(1):213-9. PubMed ID: 2983801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal.
    Zhou Y; Spangler R; LaForge KS; Maggos CE; Ho A; Kreek MJ
    J Pharmacol Exp Ther; 1996 Oct; 279(1):351-8. PubMed ID: 8859013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological regulation of tissue-CRF.
    Lymangrover JR; Brodish A
    Neuroendocrinology; 1973-1974; 13(4):234-45. PubMed ID: 4360501
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of a CRF preparation on ACTH release in rats bearing hypothalamic dexamethasone implants: a study on the "implantation paradox".
    Smelik PG
    Neuroendocrinology; 1969; 5(3):193-204. PubMed ID: 4312009
    [No Abstract]   [Full Text] [Related]  

  • 14. Responsiveness of adenohypophysial corticotrophs to hypothalamic (SME) extract remains unchanged in rats with hypothalamic lesions inhibiting CRF release.
    Stark E; Kárteszi M; Makara GB
    Neuroendocrinology; 1983 May; 36(5):330-4. PubMed ID: 6304553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotrope response to removal of releasing factors and corticosteroids in vivo.
    Dallman MF; Makara GB; Roberts JL; Levin N; Blum M
    Endocrinology; 1985 Nov; 117(5):2190-7. PubMed ID: 2995008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue CRF: an extra-hypothalamic corticotrophin releasing factor (CRF) in the peripheral blood of stressed rats.
    Lymangrover JR; Brodish A
    Neuroendocrinology; 1973; 12(4):225-35. PubMed ID: 4542398
    [No Abstract]   [Full Text] [Related]  

  • 17. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man.
    Lamberts SW; Verleun T; Oosterom R; de Jong F; Hackeng WH
    J Clin Endocrinol Metab; 1984 Feb; 58(2):298-303. PubMed ID: 6319446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role for brain corticotropin-releasing factor in the weight-reducing effects of chronic fenfluramine treatment in rats.
    Appel NM; Owens MJ; Culp S; Zaczek R; Contrera JF; Bissette G; Nemeroff CB; De Souza EB
    Endocrinology; 1991 Jun; 128(6):3237-46. PubMed ID: 1645265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of corticotropin-releasing factor (CRF) activity in the neurohypophysis of Brattleboro rats.
    Kárteszi M; Makara GB; László FA; Rappay G; Stark E
    Ann N Y Acad Sci; 1982; 394():630-3. PubMed ID: 6983849
    [No Abstract]   [Full Text] [Related]  

  • 20. CRF activity in fetal rat hypothalamus, in late pregnancy.
    Dupouy JP
    Neuroendocrinology; 1975; 19(4):303-13. PubMed ID: 179029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.